The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: A modelling approach

Journal of Public Health Medicine

Volumn 22, Issue 4, 2000, Pages 500-511

  Karnon, J ^a   Zeuner, D ^b   Ades, A E ^b   Efimba, W ^b   Brown, J ^a   Yardumian, A ^c  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Early deaths avoided; Lifetime costs; Morbidity prediction; Sickle cell disorders

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CALCULATION; CHILD; DEATH; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; HEALTH CARE COST; HEMOGLOBIN C DISEASE; HUMAN; INFANT; LIFESPAN; MODEL; MORBIDITY; MORTALITY; NATIONAL HEALTH SERVICE; NEWBORN SCREENING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; SURVIVAL;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; MODELS, ECONOMETRIC; NEONATAL SCREENING; PREGNANCY; SOCIOECONOMIC FACTORS;

EID: 0034514416     PISSN: 09574832     EISSN: None     Source Type: Journal    
DOI: 10.1093/pubmed/22.4.500     Document Type: Article

References (73)

1. The clinical features of sickle cell disease
2. Mapping the prevalence of sickle cell and beta thalassaemia in England: Estimating and validating ethnic-specific rates
3. Sickle cell disease in Britain
4. Acute admissions of patients with sickle cell disease who live in Britain
5. Patterns of mortality in sickle cell disease in the United Kingdom
6. Admissions to hospital of children with sickle cell anaemia: A study in south London
7. Sickle cell haemoglobinopathies in England
8. Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure
9. Chronic renal failure in sickle cell disease: Risk factors, clinical course and mortality
10. Sickle cell-haemoglobin C disease
11. A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems
12. Prenatal diagnosis, prenatal screening and the rise of the tentative pregnancy
13. International committee for standardisation in Haematology
14. Antenatal and neonatal haemoglobinopathy screening in the UK: Review and economic analysis
15. Other forms of sickle cell disease
16. Sickle cell-beta thalassaemia
17. New therapies and approaches to transfusion in sickle cell disease in children (review)
18. Clinical presentation of homozygous sickle cell disease
19. Clinical presentation of sickle cell-hemoglobin C disease
20. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial
21. Bacteremia in sickle hemoglobinopathies
22. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell diseases
23. Newborn screening for sickle cell disease: Effect on mortality
24. Role of splenectomy in homozygous sickle cell disease in childhood
25. Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease
26. Mortality in sickle cell disease. Life expectancy and risk factors for early death
27. Sickle cell anemia and major organ failure
28. Reducing hospital dependency in sickle cell disease: Can painful crises be managed at home?
29. Barriers to bone marrow transplantation for sickle cell anemia
30. Bone marrow transplantation for sickle cell anemia (review)
31. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
32. Bone marrow transplantation in sickle cell anemia - The dilemma of choice (editorial; comment)
33. Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results (editorial)
34. European register of patients with sickle cell disease treated with hydroxyurea is being set up (letter)
35. Lifetime treatment costs of beta thalassaemia major
36. Hospital utilization patterns and costs for adult sickle cell patients in Illinois
37. Estimating costs in cost-effectiveness analysis
38. Assessment of care of children with sickle cell disease: Implications for neonatal screening programmes
39. Penicillin prophylaxis in children with sickle cell disease in Brent
40. Cost of hospitalization associated with sickle cell disease in the United States
41. Estimating the treatment costs of breast and lung cancer
42. Pain in sickle cell disease. Rates and risk factors
43. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell diseases
44. Bacteremia in sickle hemoglobinopathies
45. The acute chest syndrome in sickle cell disease: Incidence and risk factors. Cooperative study of sickle cell diseases
46. Leg ulcers in patients with sickle cell disease
47. Surgery and anesthesia in sickle cell disease. Cooperative study of sickle cell diseases
48. Risk factors for proliferative sickle retinopathy
49. The natural history of stroke in sickle cell disease
50. The variable expression of sickle cell disease is genetically determined
51. Sickle cell anemia: Beta s-gene-cluster haplotypes as prognostic indicators of vital organ failure
52. Comprehensive care in sickle cell disease: Its impact on morbidity and mortality
53. Infections of the central nervous system
54. The management of haemoglobinopathies
55. Natural history of disease: The first two decades
56. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodes
57. Acute chest syndrome in sickle cell disease
58. Variations in the incidence, management and outcome of stroke in residents under the age of 75 in two health districts of southern England
59. Stroke (acute cerebrovascular disease)
60. Pregnancy in sickle cell disease in the UK
61. Pregnancy in sickle cell disease in the UK: Results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome
62. Management of sickle cell disease in pregnant patients
63. Management of pregnancy in sickle cell syndromes
64. Outcome of pregnancies complicated by sickle cell and sickle-C hemoglobinopathies
65. Leg ulceration
66. Community leg ulcer clinics: A comparative study in two health authorities
67. Comprehensive care in sickle cell disease: Its impact on morbidity and mortality
68. Ophthalmologic complications
69. Influence of genotype on the natural history of untreated proliferative sickle retinopathy - An angioprophic study